SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001870913-23-000018
Filing Date
2023-11-20
Accepted
2023-11-20 21:05:59
Documents
1
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1700532348.html 4  
1 FORM 4 wk-form4_1700532348.xml 4 5338
  Complete submission text file 0001870913-23-000018.txt   6901
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address
Shanmugam Muthusamy (Reporting) CIK: 0001870913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 231424264